These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 30059495)

  • 1. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
    Gregory KB; Momin AA; Coombes KR; Baladandayuthapani V
    IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(6):984-94. PubMed ID: 26146492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
    Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
    G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative network-based Bayesian analysis of diverse genomics data.
    Wang W; Baladandayuthapani V; Holmes CC; Do KA
    BMC Bioinformatics; 2013; 14 Suppl 13(Suppl 13):S8. PubMed ID: 24267288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
    Huang YT; Hsu T; Kelsey KT; Lin CL
    Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data.
    Wang W; Baladandayuthapani V; Morris JS; Broom BM; Manyam G; Do KA
    Bioinformatics; 2013 Jan; 29(2):149-59. PubMed ID: 23142963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
    Lee CH; Alpert BO; Sankaranarayanan P; Alter O
    PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-relation reconstruction from inter-relation: miRNA to gene expression.
    Kim D; Shin H; Joung JG; Lee SY; Kim JH
    BMC Syst Biol; 2013 Oct; 7 Suppl 3(Suppl 3):S8. PubMed ID: 24521265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local network component analysis for quantifying transcription factor activities.
    Shi Q; Zhang C; Guo W; Zeng T; Lu L; Jiang Z; Wang Z; Liu J; Chen L
    Methods; 2017 Jul; 124():25-35. PubMed ID: 28710010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    Fatai AA; Gamieldien J
    BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
    Chiang JH; Cheng WS; Hood L; Tian Q
    OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-analyte network markers for tumor prognosis.
    Kim J; Gao L; Tan K
    PLoS One; 2012; 7(12):e52973. PubMed ID: 23300836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.